Richard S. Finn
Hematology | Oncology
2020 Santa Monica Blvd Ste 600
Santa Monica, CA 90404
Santa Monica, CA 90404
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 251 publications
BEACON-HCC: Best evidence and north american consensus on treatment allocation for hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: July 23, 2026
Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 13, 2026
Retraction: Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.
Journal: Cancer research
Published: May 08, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.
Journal: Nature reviews. Clinical oncology
Published: May 06, 2026
Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study.
Journal: ESMO gastrointestinal oncology
Published: April 17, 2026
Advancements in intratumoral therapies for liver tumors.
Journal: Frontiers in oncology
Published: October 15, 2025
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.
Journal: Cancer research communications
Published: October 14, 2025
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma.
Journal: Annals of hepatology
Published: October 03, 2025
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 24, 2025
Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care.
Journal: Breast cancer research and treatment
Published: August 15, 2025
Interpreting immunogenicity in oncology clinical trials.
Journal: Cancer treatment reviews
Published: June 12, 2025
Clinical Feasibility of Circulating Tumor DNA in Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Journal: Liver cancer
Published: June 05, 2025
Last Updated: 09/26/2026